Logo Image
News|Articles|June 21, 2004

Now there's safe, effective relief for innocents abroad

Clinicians can now offer their patients the first nonsystemic, gastrointestinal selective antibiotic to receive FDA approval. The agency recently approved rifaximin (Xifaxan, Salix Pharmaceuticals) tablets for the treatment of TD caused by noninvasive strains of Escherichia coli in those 12 years of age or older. Rifaximin is currently approved for use in 17 countries worldwide. It is expected to be available in U.S. pharmacies in August.

Related Content

Latest CME

Advancing Pharmacist Expertise in R/R FL: Navigating Novel Therapies and Optimizing Patient Outcomes
On-Demand Webinar

Advancing Pharmacist Expertise in R/R FL: Navigating Novel Therapies and Optimizing Patient Outcomes

1.75 Credit / Hematologic Cancer, Hematology, Oncology

View more
Innovations in Hidradenitis Suppurativa Treatment: Navigating the Evolving Landscape
On-Demand Webinar

Innovations in Hidradenitis Suppurativa Treatment: Navigating the Evolving Landscape

1.0 Credits / Dermatology, Immunology

View more
Paroxysmal Nocturnal Hemoglobinuria: Managed Care Strategies to Mitigate Burden and Enhance Outcomes
Online Article

Paroxysmal Nocturnal Hemoglobinuria: Managed Care Strategies to Mitigate Burden and Enhance Outcomes

2.0 Credits / Immunology, Rare Diseases, Hematology

View more
Optimizing Outcomes in Myasthenia Gravis: Therapeutic Advances and Value-Based Care Models
On-Demand Webinar

Optimizing Outcomes in Myasthenia Gravis: Therapeutic Advances and Value-Based Care Models

1.0 Credit / Immunology, Neurology, Rare Diseases

View more
Navigating Novel Therapies in Steroid-Refractory cGVHD: Practical Strategies for Community-Based Oncology Pharmacists
On-Demand Webinar

Navigating Novel Therapies in Steroid-Refractory cGVHD: Practical Strategies for Community-Based Oncology Pharmacists

1.25 Credits / Hematologic Cancer, Oncology

View more
Reducing Transfusion Burden in Myeloid Disorders: Novel Therapeutic Strategies and Pharmacist Interventions
On-Demand Webinar

Reducing Transfusion Burden in Myeloid Disorders: Novel Therapeutic Strategies and Pharmacist Interventions

1.0 Credits / Hematologic Cancer, Oncology, Hematology

View more
Panel Discussion: Integrating Novel Combinations and Earlier Line Use in Diffuse Large B-Cell Lymphoma
On-Demand Webinar

Panel Discussion: Integrating Novel Combinations and Earlier Line Use in Diffuse Large B-Cell Lymphoma

0.5 Credit / Hematologic Cancer, Hematology, Oncology

View more
Optimizing Patient Outcomes in R/R DLBCL: Bridging Knowledge Gaps for Oncology Pharmacists in the Era of Novel Immunotherapies
On-Demand Webinar

Optimizing Patient Outcomes in R/R DLBCL: Bridging Knowledge Gaps for Oncology Pharmacists in the Era of Novel Immunotherapies

1.25 Credit / Hematologic Cancer, Hematology, Oncology

View more
Clinical Panel Debate: CAR T-Cell Therapy vs Bispecific Antibodies
On-Demand Webinar

Clinical Panel Debate: CAR T-Cell Therapy vs Bispecific Antibodies

0.5 Credit / Hematologic Cancer, Hematology, Oncology

View more
From Molecules to Medicine: Pharmacologic Principles of Innovative Non-Hodgkin Lymphoma Therapies
On-Demand Webinar

From Molecules to Medicine: Pharmacologic Principles of Innovative Non-Hodgkin Lymphoma Therapies

1.25 Credit / Hematologic Cancer, Hematology, Oncology

View more
The Pharmacist's Role in Palliative and End of Life Symptom Management (Pharmacy Technician Credit)
Online Article

The Pharmacist's Role in Palliative and End of Life Symptom Management (Pharmacy Technician Credit)

1.0 Credit / General Pharmacy

View more
The Pharmacist's Role in Palliative and End of Life Symptom Management
Online Article

The Pharmacist's Role in Palliative and End of Life Symptom Management

1.0 Credit / General Pharmacy

View more
Understanding mRNA Vaccines: Dispelling Myths and Empowering Pharmacists to Counsel Patients (Pharmacy Technician Credit)
On-Demand Webinar

Understanding mRNA Vaccines: Dispelling Myths and Empowering Pharmacists to Counsel Patients (Pharmacy Technician Credit)

1.5 Credit / Immunization, Infectious Disease

View more
Understanding mRNA Vaccines: Dispelling Myths and Empowering Pharmacists to Counsel Patients
On-Demand Webinar

Understanding mRNA Vaccines: Dispelling Myths and Empowering Pharmacists to Counsel Patients

1.5 Credit / Immunization, Infectious Disease

View more
Precision Matters: Foundations of Biomarker-Driven Care in Non-Small Cell Lung Cancer
On-Demand Webinar

Precision Matters: Foundations of Biomarker-Driven Care in Non-Small Cell Lung Cancer

1.0 Credits / Lung Cancer, Oncology

View more
From Testing to Treatment: Empowering Pharmacists to Overcome Barriers and Optimize Biomarker-Driven Care
On-Demand Webinar

From Testing to Treatment: Empowering Pharmacists to Overcome Barriers and Optimize Biomarker-Driven Care

1.0 Credits / Lung Cancer, Oncology

View more
Navigating the Legal Landscape of Telehealth: Updates and Implications for Pharmacists and Technicians (Pharmacy Technician Credit)
Online Article

Navigating the Legal Landscape of Telehealth: Updates and Implications for Pharmacists and Technicians (Pharmacy Technician Credit)

1.0 Credit / Law

View more
Navigating the Legal Landscape of Telehealth: Updates and Implications for Pharmacists and Technicians
Online Article

Navigating the Legal Landscape of Telehealth: Updates and Implications for Pharmacists and Technicians

1.0 Credit / Law

View more
Exploring Oncolytic Viruses in Melanoma: Pharmacist-Led Approaches for Safe Integration
On-Demand Virtual Symposium

Exploring Oncolytic Viruses in Melanoma: Pharmacist-Led Approaches for Safe Integration

1.0 Credits / Oncology

View more
Clinical Presentation of Hyperglycemia with PI3K and AKT Inhibitors
On-Demand Webinar

Clinical Presentation of Hyperglycemia with PI3K and AKT Inhibitors

1.0 Credits / Lung Cancer, Oncology

View more